Dificlir (Fidaxomicin) - Tillotts Pharma IE

^{This page is only intended for Irish healthcare professionals.
Adverse event reporting can be found near the bottom of the webpage. Click the bottom right button for Prescribing Information.}

Choose fidaxomicin to target C. difficile and reduce the risk of recurrent C. difficile infection (CDI)^1-3

^{1. DIFICLIR™ 200 mg film-coated tablets SmPC.

2. DIFICLIR™ 40 mg/ml granules for oral suspension SmPC.

3. Louie eT al. N Engl J Med 2011; 364: 422–31.

4. Cornely et al. Lancet Infect Dis 2012; 12: 281–9.}

^{DIFICLIR film-coated tablets is indicated for the treatment of Clostridioides difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adult and paediatric patients with a body weight of at least 12.5 kg^1,2}

PM-DIF200-IE-00016 | October 2025

Report a side effect

Adverse events should be reported. Reporting forms and information can be found at:

https://www.hpra.ie/report-an-issue/medicines-for-human-use/side-effects

Adverse events should also be reported to Tillotts Pharma UK Ltd on:

Tel: +353 1 2942015

Email: Pvireland@tillotts.com